Women, type 2 diabetes, and fracture risk. Curr Diab Rep. 2004; 4: 364–369. , .
Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab. 2001; 24: 1192–1197. , , , et al.
Discrepencies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes: a meta-analysis. Osteoporos Int. 2007; 18: 427–444. .
Diabetes mellitus, bone mineral density, and fracture risk. Curr Opin Endocrinol Diabetes Obes. 2007; 14: 429–435. , .
Osteoporosis among patients with type 1 and type 2 diabetes. Diabetes Metab. [Epub ahead of print], 2008. , , , .
Epidemiology, trends and morbidities of obesity and metabolic syndrome. Endocrine 2006; 29: 109–117. , .
Bone loss and bone turnover in diabetes. Diabetes Res Clin Pract. 1995; 44: 775–782. , , , , , .
Osteopenia associated with non-insulin-dependent diabetes mellitus: what are the causes? Diabetes Res Clin Pract. 1994; 23: 43–54. , , , , .
Diabetes mellitus: does it affect bone? Calcif Tissue Int. 2003; 73: 515–519. .
Skeletal changes in type 2 diabetic Goto-Kakizaki rats. J Endocrinol 2003; 178: 111–116. , , , , .
On measuring bone to predict osteoporotic fracture: moving beyond statistical inference. Radiology 1996; 199: 612–614. .
Role of collagen enzymatic and gycation-induced cross-slinks as a determinant of bone quality in spontaneously diabetic WBN/Kob rats. Ostoporos Int. 2006; 17: 1514–1523. , , , .
Revival of bone strength: the bottom line. J Bone Miner Res. 2005; 20: 717–720. , , , .
Examining the developing bone: what do we measure and how do we do it? J Musculoskel Neuron Interact 2005; 5: 213–224. , , .
Mechanical validation of a tomographic (pQCT) index for noninvasive. Bone. 1996; 18: 97–102. , , .
Type 2 diabetes is not independently associated with spinal trabecular volumetric bone mineral density measured by QCT in the Diabetes Heart Study. Bone. 2006; 39: 312–319. , , , et al.
Diabetes is associated independently of body composition with BMD and bone volume in older while and black men and women: the Health, Agining, and Body Composition Study. J Bone Miner Res. 2004; 19: 1084–1091. , , , et al.
Peripheral quantitative computed tomography for the detection of diabetic ostopathy: a study in the Goto-Kakizaki rat. Invest Radiol. 2003; 38: 171–176. , , , .
Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study: a large observational study of the determinants of fracture in older men. Contemp Clin Trials 2005; 26: 569–585. , , , et al.
Overview of recruitment for the osteoporotic fractures in men study (MrOS). Contemp Clin Trials 2005; 26: 557–568. , , , et al.
Factors associated with the lumbar spine and proximal femur bone mineral density in older men. Osteoporos Int. 2005; 16: 1525–1537. , , , et al.
Accuracy of the Jamar dynamometer. J Hand Ther. 1993; 6: 259–262. , , .
Physical Activity Scale for the Elderly (PASE): the relationship with activity measured by a portable accelerometer. J Sports Med Phys Fitness 1999; 39: 336–340. , .
Higher bone mineral density in older men with diabetes and impaired fasting glucose: the Osteoporotic Fractures in Men Study. Diabetes 2007; 56: A259. , , , et al.
Diabetes, fracture and bone fragility. Curr Osteoporos Rep. 2007; 5: 105–111. , .
Older women with diabetes have a higher risk of falls: a prospective study. Diabetes Care. 2002; 25: 1749–1754. , , , et al.
Risk factors for falls in older disabled women with diabetes: the women's health and aging study. J Gerontol A Biol Sci Med Sci. 2005; 60: 1539–1545. , , , , .
Etiology and prevention of age-related hip fractures. Bone. 1996; 18: 77S–86S. , , , et al.
Measuring the structural strength of bones with dual-energy X-ray absorptiometry: principles, technical limitations, and future possibilities. Osteoporos Int. 2003; 14: S81–S88. .
Osteoporosis in patients with diabetes mellitus. J Bone Miner Res. 2007; 22: 1317–1328. , , , .
Bone loss in diabetic patients with chronic kidney disease. Diabetes Med. 2007; 24: 91–93. , , , et al.
Impact of peripheral neuropathy on bone density in patients with type 1 diabetes. Diabetes Care. 1999; 22: 827–831. , , .
Impact of increased overweight on the projected prevalence of osteoporosis in older women. Ostoporos Int. 2007; 18: 307–313. , ,
Proximal femur bone geometry is appropriately adapted to lean mass in overweight children and adolescents. Bone 2005; 36: 568–576. , , , , , .
Overweight and obese children have low bone mass and area for their weight. Int J Obes Relat Metab Disord 2000; 24: 627–632. , , , , , .
Does obesity really make the femur stronger? Bone mineral density, geometry and fracture incidence in the Women's Health Initiative—observational study. J Bone Miner Res. 2009. 24: 1369–1379. , , , , .
Role of serum leptin, insulin, and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus women. Bone 2001; 29: 114–120. , , , et al.
Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone 2003; 33: 646–651. , , , et al.
Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism. J Cell Biochem. 2006; 99: 824–834. , , , et al.
Designing exercise regimens to increase bone strength. Exerc Sport Sci Rev. 2003; 31: 45–50. , .
Bone biomechanical and histomorphometrical investment in type 2 diabetic Goto-Kakizaki rats. Acta Diabetol. [Epub ahead of print], 2008. , , , , , , .
Metformin reverts deleterious effects of advance glycation end-products (AGEs) on osteoblastic cells. Exp Clin Endocrinol Diabetes [Epub ahead of print], 2008. , , , et al.
Type 2 diabetes, thiazolinediones: bad to the bone? J Clin Endocrinol Metab 2006; 91: 3276–3278. , .
Skeletal consequences of thiazolidinedione therapy. Osteoporos Int. 2008; 19: 129–137. .
Renal insufficiency-induced bone loss is associated with an increase in bone size and preservation of strength in rat proximal femur. Bone 2006; 39: 353–360. , , , et al.
Bone stiffness in men with type 2 diabetes mellitus. Metabolism 2008; 57: 1691–1695. , , , et al.